These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 20577938)

  • 21. [Classic paraneoplastic syndromes: diagnostic and treatment approach].
    Gállego Pérez-Larraya J; Dalmau J
    Neurologia; 2008 Sep; 23(7):441-8. PubMed ID: 18726722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of inflammatory and auto-immune central nervous system disorders.
    Dale RC; Brilot F
    Curr Opin Pediatr; 2010 Dec; 22(6):718-25. PubMed ID: 20871402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on paraneoplastic neurological syndromes.
    Didelot A; Honnorat J
    Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic syndromes affecting the central nervous system.
    Posner JB; Dalmau JO
    Annu Rev Med; 1997; 48():157-66. PubMed ID: 9046952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic Disorders of the Nervous System.
    Flanagan EP
    Continuum (Minneap Minn); 2020 Dec; 26(6):1602-1628. PubMed ID: 33273174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in paraneoplastic disorders of the nervous system.
    Gultekin SH
    Surg Pathol Clin; 2015 Mar; 8(1):89-99. PubMed ID: 25783824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].
    Antoine JC; Honnorat J
    Rev Neurol (Paris); 2000 Jan; 156(1):23-33. PubMed ID: 10693255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and current treatment of neurological paraneoplastic syndromes.
    Molina-Garrido MJ; Guillén-Ponce C; Martínez S; Guirado-Risueño M
    Clin Transl Oncol; 2006 Nov; 8(11):796-801. PubMed ID: 17134967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advance in immunological tests in paraneoplastic neurological syndrome.
    Fong CS
    Acta Neurol Taiwan; 2005 Mar; 14(1):28-35. PubMed ID: 15835287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paraneoplastic neurologic syndromes. Diagnostic and pathogenetic significance of autoantibodies].
    Kaiser R
    Nervenarzt; 1999 Aug; 70(8):688-701. PubMed ID: 10483569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paraneoplastic syndromes of the central nervous system].
    Silvestris N; Lucarelli A; Scaringella P; Di Ciaula A; Ambrosini S; Fata L
    Clin Ter; 2000; 151(4):279-82. PubMed ID: 11107677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraneoplastic neurological syndromes: diagnosis and treatment.
    Graus F; Dalmau J
    Curr Opin Neurol; 2007 Dec; 20(6):732-7. PubMed ID: 17992098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic syndromes affecting the nervous system.
    Dalmau JO; Posner JB
    Semin Oncol; 1997 Jun; 24(3):318-28. PubMed ID: 9208887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.